Probiotics are among the best-selling supplements — and among the most strain-specific. Here is where the clinical evidence is genuinely strong, where it is not, and how to choose a product.
What Are Probiotics
Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host (WHO/FAO definition, 2001). The human gut contains roughly 38 trillion bacteria, and this microbiome influences immune function, metabolism, mood, and disease risk.
Where the Evidence Is Strongest
1. Antibiotic-associated diarrhea. This is the strongest area in probiotic research. Lactobacillus rhamnosus GG (LGG) and Saccharomyces boulardii reduce the risk of antibiotic-associated diarrhea by 50–60%. A Cochrane review (Goldenberg et al., 2017, 82 RCTs, 11,305 participants) found high-certainty evidence for probiotics reducing it.
2. Clostridioides difficile infection prevention. There is significant evidence for S. boulardii specifically, and a Cochrane review supports its use in high-risk patients during antibiotic therapy.
3. IBS symptoms. The evidence is moderate. Multiple strains show benefit for bloating, abdominal pain, and bowel-habit normalization. The American Gastroenterological Association's 2020 clinical practice guidelines suggest probiotics for IBS patients within a clinical-trial context.
4. Ulcerative colitis remission maintenance. VSL#3 (a high-dose multi-strain probiotic) and E. coli Nissle 1917 have randomized-trial support for maintaining remission.
Where the Evidence Is Weaker
General "immune boosting" claims are mixed and strain-specific. The mental-health gut-brain axis shows promising mechanistic data but insufficient randomized-trial evidence. Weight loss currently has insufficient evidence to support probiotic use.
CFU Count — Does More Equal Better?
No. Strain specificity matters more than raw CFU count. 50 billion CFU of LGG and S. boulardii outperforms 100 billion CFU of irrelevant strains. Physician's Choice 60 Billion CFU includes 10 clinically studied strains, including L. acidophilus, L. rhamnosus, Bifidobacterium longum, and B. breve — a clinically relevant strain selection.
Survivability — What Reaches the Colon
Probiotics must survive stomach acid to reach the colon, where they exert their effects. Look for delayed-release or acid-resistant capsules, established acid-resistant strains (LGG and S. boulardii are naturally more resistant), and shelf-stable formulations with potency guaranteed at expiration — not merely at manufacture.
Dosing
Dosing varies by strain and indication. Most clinical trials use 1–10 billion CFU for maintenance, and higher doses (50–100 billion CFU) for acute situations such as during a course of antibiotics.
When to Take
Generally, 30 minutes before a meal or with food. If you are taking antibiotics, take probiotics at least 2 hours apart from the antibiotic dose to avoid killing the probiotic bacteria.
Safety
Probiotics are extremely safe for healthy adults — one of the best safety profiles of any supplement category. One important exception: severely immunocompromised patients should consult a physician, because rare cases of probiotic bacteremia have been reported in ICU and severely immunocompromised settings.
This site contains affiliate links. If you purchase through our link we may earn a commission at no extra cost to you.
Physician's Choice 60 Billion CFU Probiotic includes 10 clinically studied strains plus organic prebiotics in a shelf-stable, delayed-release capsule with potency guaranteed through expiration:
View Probiotic Supplement on Amazon →Sources
- Goldenberg et al. (2017). Cochrane Database of Systematic Reviews. Probiotics for antibiotic-associated diarrhea.
- American Gastroenterological Association Clinical Practice Guidelines on Probiotics (2020).
- WHO/FAO (2001). Probiotic definition.
- Cochrane Review: C. difficile prevention.